The Primary
Care Companionfor CNS Disorders

Child and Adolescent Psychiatry

Letter to the Editor April 15, 2008

Factors Influencing Adherence in Children and Adolescents Treated With Antipsychotics or Antidepressants

Kurosch Yazdi, M.D.; Gabriele Unterlass, M.D.; Georg Kemmler, Ph.D.; Karl Kralovec, M.D.; Wolfgang Aichhorn, M.D.

Prim Care Companion J Clin Psychiatry 2008;10(2):160-161

Article Abstract

Letter to the Editor

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue

Letter to the Editor

Harm Reduction in Adolescent Inhalant Use

October 15, 2024

The authors discuss harm reduction efforts targeting inhalant use in the adolescent population.

Vania Modesto-Lowe, Roseane Rodrigues, Deanna Sgambato

Letter to the Editor

Priapism Use in a 12-Year-Old Boy After Lisdexamfetamine

December 7, 2017

Priapism is an infrequent presentation in children. The FDA issued a safety announcement in 2013 warning of the risk of priapism with the use of methylphenidate and atomoxetine. Here,...

Muhammad Hassan Majeed, Ali Ahsan Ali, Tamoor Mirza

Letter to the Editor

Dialectical Behavior Therapy for Misophonia in Adolescence

September 14, 2017

Misophonia, characterized by increased sensitivity to sound, results in intense emotional and behavioral responses to triggering auditory stimuli. Jenny is a 16-year-old girl with misophonia and social anxiety who...

Rebecca C. Kamody, Garry S. Del Conte

Factors Influencing Adherence in Children and Adolescents Treated With Antipsychotics or Antidepressants

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

ELSEWHERE:

FOLLOW US:

Factors Influencing Adherence in Children and Adolescents Treated With Antipsychotics or Antidepressants

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

Related Articles

Harm Reduction in Adolescent Inhalant Use

Priapism Use in a 12-Year-Old Boy After Lisdexamfetamine

Dialectical Behavior Therapy for Misophonia in Adolescence

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles